TCM Biotech International
CompanyTaiwan
TCM Biotech International develops one asset, in human trials (LivPhcD in NAFLD). Mostly supplement; based in Taiwan.
- 1
- Asset
- Furthest stage
- Human trials
- 1
- Trial
- 0
- Signals
Pipeline
1Hepatoprotective dietary supplement for non-alcoholic fatty liver disease.
Human trials, Supplement, NAFLD
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials1
- Similar companies2